Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARF like GTPase 2 binding protein pseudogene 7 (ARL2BPP7) is a human pseudogene[3]. Pseudogenes resemble their parent protein-coding genes but usually lack protein-coding ability due to disruptive mutations or lack of regulatory elements. No known biological function, disease association, or pharmacological relevance is attributed to ARL2BPP7. Its name is derived from the functional gene "ARF like GTPase 2 binding protein" (ARL2BP); however, ARL2BP is a distinct protein-coding gene with established biological roles, whereas ARL2BPP7 is a pseudogene variant and is not considered a therapeutic target or biomarker[3][7]. ARL2BPP7 is not a therapeutically relevant target, nor is it a known protein with biological function, but is a pseudogene—so for purposes of target-based drug discovery or disease association, it is both *not a target* and *incorrect* to consider it as such. If information about therapeutic targets is needed, you should instead refer to **ARL2BP (ARF like GTPase 2 binding protein)**, which is a functional protein-coding gene linked, for example, to retinitis pigmentosa and ciliopathies, but this information does NOT pertain to ARL2BPP7[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARF like GTPase 2 binding protein pseudogene 7 (ARL2BPP7).